60
Participants
Start Date
November 15, 2018
Primary Completion Date
December 13, 2019
Study Completion Date
February 25, 2020
Exparel Injectable Product
Liposomal bupivacaine 20 cc (226 mg) + Bupivacaine Hydrochloride 0.25% 40 cc (100 mg) + made up to calculated volume with normal saline solution based on the length of the incision and number of chest tubes (20 cc per tube + 20cc per inch of incision)
Bupivacaine Hydrochloride
Bupivacaine 0.25% 2 mg/kg not to exceed 150 mg - made up to made up to calculated volume with normal saline solution based on the length of the incision and number of chest tubes (20 cc per tube + 20cc per inch of incision)
UPMC Presbyterian Hospital, Pittsburgh
Collaborators (1)
Pacira Pharmaceuticals, Inc
INDUSTRY
Kathirvel Subramaniam
OTHER